Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection

Hiddo J.L. Heerspink, Remo H.M. Furtado, Otavio Berwanger, Gary G. Koch, Felipe Martinez, Omar Mukhtar, Subodh Verma, Samvel B. Gasparyan, Fengming Tang, Sheryl L. Windsor, Vicente Cés de Souza-Dantas, Mildren del Sueldo, Robert Frankel, Ali Javaheri, Rafael A. Maldonado, Caryn Morse, Marco Mota-Gomes, Douglas Shemin, Osvaldo Lourenço Silva, Alexandre Pereira Tognon, Marcel Twahirwa, Joan Buenconsejo, Russell Esterline, Jan Oscarsson, Philip Ambery, Anna Maria Langkilde, Mikhail N. Kosiborod

Open source

DOI
10.2215/cjn.14231021
Published
2022-05
Container
Clinical Journal of the American Society of Nephrology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2215/cjn.14231021,
  title = {Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection},
  author = {Hiddo J.L. Heerspink and Remo H.M. Furtado and Otavio Berwanger and Gary G. Koch and Felipe Martinez and Omar Mukhtar and Subodh Verma and Samvel B. Gasparyan and Fengming Tang and Sheryl L. Windsor and Vicente Cés de Souza-Dantas and Mildren del Sueldo and Robert Frankel and Ali Javaheri and Rafael A. Maldonado and Caryn Morse and Marco Mota-Gomes and Douglas Shemin and Osvaldo Lourenço Silva and Alexandre Pereira Tognon and Marcel Twahirwa and Joan Buenconsejo and Russell Esterline and Jan Oscarsson and Philip Ambery and Anna Maria Langkilde and Mikhail N. Kosiborod},
  year = {2022},
  journal = {Clinical Journal of the American Society of Nephrology},
  doi = {10.2215/cjn.14231021},
  url = {https://doi.org/10.2215/cjn.14231021}
}

RIS

TY  - JOUR
TI  - Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection
AU  - Hiddo J.L. Heerspink
AU  - Remo H.M. Furtado
AU  - Otavio Berwanger
AU  - Gary G. Koch
AU  - Felipe Martinez
AU  - Omar Mukhtar
AU  - Subodh Verma
AU  - Samvel B. Gasparyan
AU  - Fengming Tang
AU  - Sheryl L. Windsor
AU  - Vicente Cés de Souza-Dantas
AU  - Mildren del Sueldo
AU  - Robert Frankel
AU  - Ali Javaheri
AU  - Rafael A. Maldonado
AU  - Caryn Morse
AU  - Marco Mota-Gomes
AU  - Douglas Shemin
AU  - Osvaldo Lourenço Silva
AU  - Alexandre Pereira Tognon
AU  - Marcel Twahirwa
AU  - Joan Buenconsejo
AU  - Russell Esterline
AU  - Jan Oscarsson
AU  - Philip Ambery
AU  - Anna Maria Langkilde
AU  - Mikhail N. Kosiborod
PY  - 2022
JO  - Clinical Journal of the American Society of Nephrology
DO  - 10.2215/cjn.14231021
UR  - https://doi.org/10.2215/cjn.14231021
ER  - 

APA

Heerspink, H. J., Furtado, R. H., Berwanger, O., Koch, G. G., Martinez, F., Mukhtar, O., Verma, S., Gasparyan, S. B., Tang, F., Windsor, S. L., Souza-Dantas, V. C. D., Sueldo, M. D., Frankel, R., Javaheri, A., Maldonado, R. A., Morse, C., Mota-Gomes, M., Shemin, D., Silva, O. L., Tognon, A. P., Twahirwa, M., Buenconsejo, J., Esterline, R., Oscarsson, J., Ambery, P., Langkilde, A. M., & Kosiborod, M. N. (2022). Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.14231021

Source records